Browse Articles

Discover research articles across all indexed journals

Internal friction evidence for the carbides-formation in the high Co–Ni martensite steel during heat treatment

Scientific Reports Xian-Yu Li, Gang-Ling Hao, Tao-Li Gao et al. Mar 20, 2025 DOI: 10.1038/s41598-025-93709-8

Abstract The internal friction (IF) behaviors, combined with X-ray diffraction (XRD), dilatometry, and transmission electron microscopy (TEM) analysis of the cryogenic treated and tempered M54 steel were systematically investigated. In IF-temperature curves, the peak P1 was proved to be a Snoek-Ke-Koester (SKK) relaxation peak associated with interstitial carbon atoms in martensite matrix according to its activation energy. The peak P2 and P3 were attributed to reverse martensite transformation and martensite transformation, respectively, during the thermal cycle. Based on the analysis results of IF, XRD and TEM, M2C precipitation indeed occurred during tempering, leading to final ultra-high strength and hardness of the aged M54 steel.

Multimodal feature fusion machine learning for predicting chronic injury induced by engineered nanomaterials

Nature Communications Yang Huang, Jiayu Cao, Xuehua Li et al. Mar 20, 2025 DOI: 10.1038/s41467-025-58016-w

Computationally designed multi-epitope vaccine construct targeting the SARS-CoV-2 spike protein elicits robust immune responses in silico

Scientific Reports Varughese Deepthi, Aswathy Sasikumar, Kochupurackal P Mohanakumar et al. Mar 20, 2025 DOI: 10.1038/s41598-025-92956-z

Sublethal systemic LPS in mice enables gut-luminal pathogens to bloom through oxygen species-mediated microbiota inhibition

Nature Communications Sanne Kroon, Dejan Malcic, Lena Weidert et al. Mar 20, 2025 DOI: 10.1038/s41467-025-57979-0

Abstract Endotoxin-driven systemic immune activation is a common hallmark across various clinical conditions. During acute critical illness, elevated plasma lipopolysaccharide triggers non-specific systemic immune activation. In addition, a compositional shift in the gut microbiota, including an increase in gut-luminal opportunistic pathogens, is observed. Whether a causal link exists between acute endotoxemia and abundance of gut-luminal opportunistic pathogens is incompletely understood. Here, we model acute, pathophysiological lipopolysaccharide concentrations in mice and show that systemic exposure promotes a 100–10’000-fold expansion of Klebsiella pneumoniae, Escherichia coli, Enterococcus faecium and Salmonella Typhimurium in the gut within one day, without overt enteropathy. Mechanistically, this is driven by a Toll-like receptor 4-dependent increase in gut-luminal oxygen species levels, which transiently halts microbiota fermentation and fuels growth of gut-luminal facultative anaerobic pathogens through oxidative respiration. Thus, systemic immune activation transiently perturbs microbiota homeostasis and favours opportunistic pathogens, potentially increasing the risk of infection in critically ill patients.

Evolution of coopetition between real estate enterprises and urban investment construction companies under an agent construction system

Scientific Reports Shaoliang Li, Xiazhong Zheng, Kesheng Yan et al. Mar 20, 2025 DOI: 10.1038/s41598-025-92853-5

Accessible homeostatic gastric organoids reveal secondary cell type-specific host-pathogen interactions in Helicobacter pylori infections

Nature Communications Moritz Hofer, Youlim Kim, Nicolas Broguiere et al. Mar 20, 2025 DOI: 10.1038/s41467-025-57131-y

Neural correlates of suppressing and imagining future threat

Scientific Reports Stefan G. Hofmann, Christoph Vogelbacher, Verena Schuster et al. Mar 20, 2025 DOI: 10.1038/s41598-025-94580-3

Abstract Suppressing upsetting thoughts can cause psychological distress but might also enhance mental health when used flexibly to suppress the imagination of future threat during challenging times. To investigate the neural correlates of suppressing and imagining future threat, a cohort of 65 participants underwent a previously examined "Imagine/No-Imagine" paradigm while examining brain activation using magnetic resonance imaging. We observed activity of the inferior frontal gyrus, middle frontal gyrus (MFG), superior parietal lobule, and superior occipital sulcus during thought suppression, whereas imagining future threat elicited activation in the bilateral posterior cingulate cortex (PCC) and ventromedial prefrontal cortex (vmPFC). Subjective levels of anxiety, stress, and depression as covariates did not alter these results. To further examine the group and individual-level network dynamics, we conducted dynamic causal modeling (DCM) and group iterative multiple model estimations (GIMME). The DCM model showed that during suppression, the MFG positively influenced the vmPFC and right PCC. In contrast, the vmPFC and the left and right PCC showed positive connections to the MFG during imagining. This suggests that the neural correlates of self-regulation involve an information flow between the PCC and the PFC. In addition, GIMME identified group-level connections between the right and left PCC and between the left PCC and vmPFC, reflecting the information flow during suppression and imagination of future threat, respectively. Considerable interindividual heterogeneity in the connectivity patterns became apparent, pointing to the existence of different biotypes.

Computational memory capacity predicts aging and cognitive decline

Nature Communications Mite Mijalkov, Ludvig Storm, Blanca Zufiria-Gerbolés et al. Mar 20, 2025 DOI: 10.1038/s41467-025-57995-0

Abstract Memory is a crucial cognitive function that deteriorates with age. However, this ability is normally assessed using cognitive tests instead of the architecture of brain networks. Here, we use reservoir computing, a recurrent neural network computing paradigm, to assess the linear memory capacities of neural-network reservoirs extracted from brain anatomical connectivity data in a lifespan cohort of 636 individuals. The computational memory capacity emerges as a robust marker of aging, being associated with resting-state functional activity, white matter integrity, locus coeruleus signal intensity, and cognitive performance. We replicate our findings in an independent cohort of 154 young and 72 old individuals. By linking the computational memory capacity of the brain network with cognition, brain function and integrity, our findings open new pathways to employ reservoir computing to investigate aging and age-related disorders.

Analysis of the mitochondrial genome of Neuroctenus hainanensis and the phylogenetic position of Aradoidea

Scientific Reports Yanrui Li, Liangpeng Ji, Xiaoshuan Bai Mar 20, 2025 DOI: 10.1038/s41598-025-93375-w

Sparse haplotype-based fine-scale local ancestry inference at scale reveals recent selection on immune responses

Nature Communications Yaoling Yang, Richard Durbin, Astrid K. N. Iversen et al. Mar 20, 2025 DOI: 10.1038/s41467-025-57601-3

Abstract Increasingly efficient methods for inferring the ancestral origin of genome regions are needed to gain insights into genetic function and history as biobanks grow in scale. Here we describe two near-linear time algorithms to learn ancestry harnessing the strengths of a Positional Burrows-Wheeler Transform. SparsePainter is a faster, sparse replacement of previous model-based ‘chromosome painting’ algorithms to identify recently shared haplotypes, whilst PBWTpaint uses further approximations to obtain lightning-fast estimation optimized for genome-wide relatedness estimation. The computational efficiency gains of these tools for fine-scale local ancestry inference offer the possibility to analyse large-scale genomic datasets using different approaches. Application to the UK Biobank shows that haplotypes better represent ancestries than principal components, whilst linkage-disequilibrium of ancestry identifies signals of recent changes to population-specific selection for many genomic regions associated with immune responses, suggesting avenues for understanding the pathogen-immune system interplay on a historical timescale.

Analysis of ABCG2 gene rs2231142 single nucleotide polymorphism and risk factors in hyperuricemia

Scientific Reports Meiting Liang, Xingxing Liu, Meng Sun et al. Mar 20, 2025 DOI: 10.1038/s41598-025-93312-x

Molecular light-to-heat conversion promotes orthogonal synthesis and assembly of metal-organic frameworks

Nature Communications Aritra Biswas, Nir Lemcoff, Ofir Shelonchik et al. Mar 20, 2025 DOI: 10.1038/s41467-025-57933-0

Gallic and glycyrrhetinic acids prevent azithromycin-induced liver damage in rats by mitigating oxidative stress and inflammation

Scientific Reports Marwa Ahmed Mohamed Ali, Asmaa Ibrahim Matouk, Alaaeldin Ahmed Hamza et al. Mar 20, 2025 DOI: 10.1038/s41598-025-93120-3

Transport and InsP8 gating mechanisms of the human inorganic phosphate exporter XPR1

Nature Communications Qinyu Zhu, Madeleine F. Yaggi, Nikolaus Jork et al. Mar 20, 2025 DOI: 10.1038/s41467-025-58076-y

MRD-guided zanubrutinib, venetoclax, and obinutuzumab in relapsed CLL: primary end point analysis from the CLL2-BZAG trial

Blood Moritz Fürstenau, Sandra Robrecht, Christof Schneider et al. Mar 20, 2025 DOI: 10.1182/blood.2024026685

Abstract The phase 2 CLL2-BZAG trial tested a measurable residual disease (MRD)–guided combination treatment of zanubrutinib, venetoclax, and obinutuzumab after an optional bendamustine debulking in patients with relapsed/refractory chronic lymphocytic leukemia (CLL). In total, 42 patients were enrolled and 2 patients with ≤2 induction cycles were excluded from the analysis population per protocol. Patients had a median of 1 prior therapy (range, 1-5); 18 patients (45%) had already received a Bruton tyrosine kinase (BTK) inhibitor (BTKi); 7 patients (17.5%) venetoclax; and, of these, 5 (12.5%) had received both. Fifteen patients (37.5%) had a TP53 mutation/deletion, and 31 (77.5%) had unmutated immunoglobulin heavy chain variable region gene. With a median observation time of 21.5 months (range, 8.0-35.3) the most common adverse events were COVID-19 (n = 26 patients), diarrhea (n = 15), infusion-related reactions (n = 15), thrombocytopenia (n = 14), nausea (n = 12), fatigue (n = 12), and neutropenia (n = 12). Two patients had fatal adverse events (COVID-19, and fungal pneumonia secondary to COVID-19). After 6 months of the triple combination, all patients responded, and 21 (52.5%; 95% confidence interval, 36.1-68.5) showed undetectable MRD (uMRD) in the peripheral blood. In many patients, remissions deepened over time, with a best uMRD rate of 85%. The estimated progression-free and overall survival rates at 18 months were 96% and 96.8%, respectively. No patient has yet required a subsequent treatment. In summary, the MRD-guided triple combination of zanubrutinib, venetoclax, and obinutuzumab induced deep remissions in a relapsed CLL population enriched for patients previously treated with a BTKi/venetoclax. This trial was registered at www.clinicaltrials.gov as #NCT04515238.

Characterization and confirmation of the long lifetime of a-decade-aged hydroxyapatite ceramic electrets

Scientific Reports Kosuke Nozaki, Kazuaki Hashimoto, Noriyuki Wakabayashi et al. Mar 20, 2025 DOI: 10.1038/s41598-025-94185-w

Math models expose myeloid bias mechanisms in hematopoiesis

Blood Artur C. Fassoni, Ingmar Glauche Mar 20, 2025 DOI: 10.1182/blood.2024027777

Regulation of WNT16 in bone may involve upstream enhancers within CPED1

Scientific Reports N. Martínez-Gil, C. Herrera-Ubeda, N. Gritti et al. Mar 20, 2025 DOI: 10.1038/s41598-025-93259-z

How I treat patients with AML using azacitidine and venetoclax

Blood Andrew H. Wei, Sun Loo, Naval Daver Mar 20, 2025 DOI: 10.1182/blood.2024024009

Abstract Venetoclax (VEN) received full approval in October 2020 for use in older patients who are unfit with acute myeloid leukemia (AML) combined with either hypomethylating agents or low-dose cytarabine. This ended a semicentennial of stalled clinical progress and initiated a new treatment option with proven capacity to enhance response and prolong survival in older patients with AML. Despite widespread use of azacitidine-VEN (AZA-VEN), there is increasing appreciation that this regimen is myelosuppressive and associated with a higher risk of infectious complications than AZA alone. Key principles of initial management include prevention of tumor lysis syndrome in patients at high risk and minimizing infectious complications during induction. In the postremission phase, limiting cumulative marrow suppression by allowing sufficient time between cycles for optimal marrow recovery and truncating the duration of VEN exposure for those with delayed blood count recovery have emerged as important axioms of effective care. This article casts a clinical spotlight on important challenges and dilemmas encountered in practice. We also outline a structured framework to assist in the safe management of AZA-VEN in the clinic.

A hybrid object detection approach for visually impaired persons using pigeon-inspired optimization and deep learning models

Scientific Reports Abdullah M. Alashjaee, Hussah Nasser AlEisa, Abdulbasit A. Darem et al. Mar 20, 2025 DOI: 10.1038/s41598-025-92239-7